Nitric Oxide Therapeutics in Pulmonary Vascular Disease

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    Pulmonology;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 4;    PH Medications;    symptoms;    PPHN;    Systolic dysfunction;    Chronic thromboembolic pulmonary hypertension;    Oral therapy;    Calcium channel blockers;    Phosphodiesterase Inhibitors (PDE-5 Inhibitors);    nitric oxide;    Anticoagulation;    Inotropes;    RV Size;    Vasodilator study;    Acute vasodialtor challenge;    Pulmonary vascular resistance;    Cardiac Index;    Fick;    Thermodilution;    exercise hemodynamic testing;    thromboendarterectomy;    vascular remodeling;    endothelial proliferation;    endothelial dysfunction;    Endothelin;    tricuspid regurgitation;    hypoxia;    Drug development;    clinical trial;    clinical trial endpoints;    CME;    Classification;    Epidemiology;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 授权许可】

All Rights reserved